Page last updated: 2024-08-25

quindoxin and Carcinoma, Anaplastic

quindoxin has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Khatib, M; Gali-Muhtasib, H; Geara, F; Haddadin, MJ	1

Other Studies

1 other study(ies) available for quindoxin and Carcinoma, Anaplastic

Article	Year
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21. Radiation oncology (London, England), 2010, Nov-15, Volume: 5 Topics: Antineoplastic Agents; Carcinoma; Cell Death; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Quinoxalines; Tumor Suppressor Protein p53	2010

Article

Year

Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.

Radiation oncology (London, England), 2010, Nov-15, Volume: 5

Topics: Antineoplastic Agents; Carcinoma; Cell Death; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Quinoxalines; Tumor Suppressor Protein p53

2010